COMMUNIQUÉS West-GlobeNewswire

Basilea reports half-year financial results reflecting strong in-market product sales growth in addition to progress and expansion of the R&D pipeline
14/08/2018
Total revenue increased by 30% to CHF 59.9 million; 2018 total revenue guidance is increased to CHF 120 - 130 million Royalties on Cresemba sales more than doubled to CHF 10.8 million Clinical oncology pipeline [...]
Curetis Announces Change in Curetis USA Inc. Management
14/08/2018
Curetis Announces Change in Curetis USA Inc. Management Christopher M. Bernard resigns as President & CEO of Curetis USA Inc. effective August 31, 2018 Chris D. Emery to succeed as President & CEO of Curetis USA [...]
Novartis appoints Dr. Klaus Moosmayer as Chief Ethics Risk and Compliance Officer
14/08/2018
Basel, August 14, 2018 - Novartis announced today the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the [...]
Merus annonce ses résultats financiers pour le deuxième trimestre 2018 et ses résultats d'exploitation intermédiaires
14/08/2018
Les données cliniques de la phase 1/2 de MCLA-128 tirées de la cohorte de patients atteints d'un cancer gastrique seront présentées à l'occasion du congrès de la Société européenne d'oncologie médicale (European Society [...]
Reviewed Financial Statement's announcement for the period 30 June 2018
13/08/2018
EASTPHARMA LTD. London, 13 August 2018 - EastPharma (EAST LI) announces that it is releasing its reviewed financial statements for the period 30 June 2018 and a review of its main subsidiary DEVA Holding's financial [...]
XBiotech présente une mise à jour trimestrielle de ses activités
13/08/2018
L'entreprise fournit une vue d'ensemble sur sa position financière et ses avancées dans les domaines clinique et de la recherche AUSTIN, Texas, 13 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) a fourni une [...]
Allscripts open ecosystem drives healthcare data interoperability
13/08/2018
Global health IT leader enables more than four billion API data shares since 2013; applauds Microsoft and others’ joint commitment to help move healthcare towards the cloud CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- [...]
The Cooper Companies to Participate in the Baird Global Healthcare Conference
13/08/2018
PLEASANTON, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Baird 2018 Global Healthcare Conference in New York, NY, on September 5, 2018. Albert G. White III, [...]
Mustang Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
13/08/2018
NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
ImmuCell Announces Financial Results for Second Quarter of 2018
13/08/2018
PORTLAND, Maine, Aug. 13, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for Antibody-Coupled T Cell Receptor (ACTR) platform in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers
13/08/2018
– First Solid Tumor Product Candidate Based on Unum’s universal ACTR Technology – – Phase 1 Study Expected to Initiate by the End of 2018 – CAMBRIDGE, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. ( [...]
Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT) RANCHO CORDOVA, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, [...]
Unum Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update
13/08/2018
– IND for First Solid Tumor Program, ACTR T cells in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers Now Active; Expect to Initiate Phase I Trial by End of 2018 – CAMBRIDGE, Mass., Aug. 13, 2018 ( [...]
electroCore, Inc. Announces Second Quarter Financial Results
13/08/2018
BASKING RIDGE, N.J., Aug. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three month and six [...]
Acer Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Medical Affairs and Quality NEWTON, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a [...]
Forty Seven Inc. Reports Second Quarter 2018 Financial Results and Recent Business Highlights
13/08/2018
-- Presented Preliminary Data from Three Clinical Trials of 5F9 as a Monotherapy and Combination Agent -- -- Granted Fast Track Designation from the U.S. Food and Drug Administration for 5F9 in Diffuse Large B-Cell [...]
Achaogen to Present at the Wedbush PacGrow Healthcare Conference
13/08/2018
-- Company presentation scheduled for August 14, 2018 at 8:00 a.m. EDT -- SOUTH SAN FRANCISCO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing [...]
Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
LIVONIA, Mich., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]
Avinger Announces Second Quarter 2018 Financial Results
13/08/2018
REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended [...]

Pages